Jon J. Vernon

1.1k total citations
25 papers, 832 citations indexed

About

Jon J. Vernon is a scholar working on Infectious Diseases, Epidemiology and Periodontics. According to data from OpenAlex, Jon J. Vernon has authored 25 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 10 papers in Epidemiology and 5 papers in Periodontics. Recurrent topics in Jon J. Vernon's work include Clostridium difficile and Clostridium perfringens research (17 papers), Microscopic Colitis (10 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Jon J. Vernon is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (17 papers), Microscopic Colitis (10 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Jon J. Vernon collaborates with scholars based in United Kingdom, Slovenia and Switzerland. Jon J. Vernon's co-authors include Mark H. Wilcox, Jane Freeman, K. Morris, Christopher Longshaw, Scott Nicholson, S. L. Todhunter, Monique J. T. Crobach, Séverine Péchiné, Ling Yuan Kong and Vivian G. Loo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Microbiology Reviews and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jon J. Vernon

25 papers receiving 825 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jon J. Vernon 719 423 166 153 116 25 832
Ingrid M. J. G. Sanders 681 0.9× 362 0.9× 276 1.7× 165 1.1× 71 0.6× 36 897
Giovanni Gesu 213 0.3× 201 0.5× 102 0.6× 79 0.5× 83 0.7× 33 576
Gary D. Rifkin 643 0.9× 301 0.7× 70 0.4× 64 0.4× 95 0.8× 15 746
Michelle M. Merrigan 911 1.3× 477 1.1× 140 0.8× 172 1.1× 97 0.8× 16 946
Francesca Crea 220 0.3× 213 0.5× 88 0.5× 97 0.6× 18 0.2× 21 612
K. Morris 725 1.0× 506 1.2× 79 0.5× 126 0.8× 116 1.0× 10 800
Adam Cheknis 979 1.4× 537 1.3× 269 1.6× 234 1.5× 81 0.7× 19 1.1k
Haluk Güri̇z 131 0.2× 302 0.7× 68 0.4× 45 0.3× 27 0.2× 36 487
Wolfgang Barousch 142 0.2× 215 0.5× 67 0.4× 154 1.0× 16 0.1× 14 455
Florian Daxböck 175 0.2× 183 0.4× 56 0.3× 80 0.5× 79 0.7× 14 475

Countries citing papers authored by Jon J. Vernon

Since Specialization
Citations

This map shows the geographic impact of Jon J. Vernon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon J. Vernon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon J. Vernon more than expected).

Fields of papers citing papers by Jon J. Vernon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon J. Vernon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon J. Vernon. The network helps show where Jon J. Vernon may publish in the future.

Co-authorship network of co-authors of Jon J. Vernon

This figure shows the co-authorship network connecting the top 25 collaborators of Jon J. Vernon. A scholar is included among the top collaborators of Jon J. Vernon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon J. Vernon. Jon J. Vernon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vernon, Jon J., David W. Eyre, M. H. Wilcox, & Jane Freeman. (2025). Molecular clock complexities of Clostridioides difficile. Anaerobe. 93. 102953–102953. 1 indexed citations
2.
Vernon, Jon J.. (2025). Modulation of the Human Microbiome: Probiotics, Prebiotics, and Microbial Transplants. Advances in experimental medicine and biology. 1472. 277–294. 2 indexed citations
3.
Freeman, Jane, Virginie Viprey, Emma Clark, et al.. (2024). Antimicrobial susceptibility in Clostridioides difficile varies according to European region and isolate source. JAC-Antimicrobial Resistance. 6(4). dlae112–dlae112. 1 indexed citations
4.
Yu, Xin, Deirdre DeVine, & Jon J. Vernon. (2024). Manipulating the diseased oral microbiome: the power of probiotics and prebiotics. Journal of Oral Microbiology. 16(1). 2307416–2307416. 18 indexed citations
5.
Costeira, Ricardo, Jon J. Vernon, Susan Joseph, et al.. (2023). Hemin availability induces coordinated DNA methylation and gene expression changes in Porphyromonas gingivalis. mSystems. 8(4). e0119322–e0119322. 4 indexed citations
6.
7.
Vernon, Jon J., Emma Black, Deirdre DeVine, et al.. (2022). Increased Handpiece Speeds without Air Coolant: Aerosols and Thermal Impact. Journal of Dental Research. 102(1). 53–60. 5 indexed citations
8.
Vernon, Jon J., Emma Black, Deirdre DeVine, et al.. (2021). Dental Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2. Journal of Dental Research. 100(13). 1461–1467. 24 indexed citations
9.
10.
11.
Tronci, Giuseppe, et al.. (2020). Antimicrobial Dye-Conjugated Polyglobalide-Based Organogels. ACS Applied Polymer Materials. 2(7). 2927–2933. 15 indexed citations
12.
Davies, Kerrie, Virginie Viprey, Jon J. Vernon, et al.. (2020). Burden of Clostridium difficile Infection (CDI) Across Whole Healthcare Economies and European Borders; COMBACTE-CDI Results. Infection Control and Hospital Epidemiology. 41(S1). s24–s25. 1 indexed citations
13.
Freeman, Jane, Jon J. Vernon, K. Morris, et al.. (2019). Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study. European Journal of Clinical Microbiology & Infectious Diseases. 39(1). 169–177. 57 indexed citations
14.
Vernon, Jon J., et al.. (2019). Investigating the transient and persistent effects of heat on Clostridium difficile spores. Journal of Medical Microbiology. 68(10). 1445–1454. 3 indexed citations
15.
16.
Freeman, Jane, Jon J. Vernon, K. Morris, et al.. (2017). The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011–2014. Clinical Microbiology and Infection. 24(7). 724–731. 106 indexed citations
17.
Crowther, G. S., C. H. Chilton, Christopher Longshaw, et al.. (2016). Efficacy of vancomycin extended-dosing regimens for treatment of simulatedClostridium difficileinfection within anin vitrohuman gut model. Journal of Antimicrobial Chemotherapy. 71(4). 986–991. 13 indexed citations
18.
Corbett, David F., Andrew K. Wise, Peter Warn, et al.. (2015). In vitro susceptibility of Clostridium difficile to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against C. difficile. Journal of Antimicrobial Chemotherapy. 70(6). 1751–1756. 35 indexed citations
19.
Freeman, Jane, Jon J. Vernon, Richard Vickers, & Mark H. Wilcox. (2015). Susceptibility of Clostridium difficile Isolates of Varying Antimicrobial Resistance Phenotypes to SMT19969 and 11 Comparators. Antimicrobial Agents and Chemotherapy. 60(1). 689–692. 24 indexed citations
20.
Freeman, Jane, Jon J. Vernon, K. Morris, et al.. (2014). Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes. Clinical Microbiology and Infection. 21(3). 248.e9–248.e16. 217 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ingrid M. J. G. Sanders Breakdown of academic impact, for papers by Giovanni Gesu Breakdown of academic impact, for papers by Gary D. Rifkin Breakdown of academic impact, for papers by Michelle M. Merrigan Breakdown of academic impact, for papers by Francesca Crea Breakdown of academic impact, for papers by K. Morris Breakdown of academic impact, for papers by Adam Cheknis Breakdown of academic impact, for papers by Haluk Güri̇z Breakdown of academic impact, for papers by Wolfgang Barousch Breakdown of academic impact, for papers by Florian Daxböck
Rankless by CCL
2026